SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply (2021)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(21)00194-1
PubMed Identifier: 34119033
Publication URI: http://europepmc.org/abstract/MED/34119033
Type: Journal Article/Review
Parent Publication: The Lancet Gastroenterology & Hepatology
Issue: 7